X-154097618-GCCT-GCCTCCT
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001110792.2(MECP2):c.45_47dupAGG(p.Gly16dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00182 in 1,028,331 control chromosomes in the GnomAD database, including 3 homozygotes. There are 420 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★★★).
Frequency
Genomes: 𝑓 0.0018 ( 0 hom., 38 hem., cov: 20)
Exomes 𝑓: 0.0018 ( 3 hom. 382 hem. )
Consequence
MECP2
NM_001110792.2 disruptive_inframe_insertion
NM_001110792.2 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.66
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-154097618-G-GCCT is Benign according to our data. Variant chrX-154097618-G-GCCT is described in ClinVar as [Benign]. Clinvar id is 158882.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00181 (189/104220) while in subpopulation AFR AF= 0.00331 (96/29030). AF 95% confidence interval is 0.00277. There are 0 homozygotes in gnomad4. There are 38 alleles in male gnomad4 subpopulation. Median coverage is 20. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 38 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MECP2 | NM_001110792.2 | c.45_47dupAGG | p.Gly16dup | disruptive_inframe_insertion | 1/3 | ENST00000453960.7 | NP_001104262.1 | |
MECP2 | NM_004992.4 | c.-116_-114dupAGG | 5_prime_UTR_variant | 1/4 | ENST00000303391.11 | NP_004983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MECP2 | ENST00000453960.7 | c.45_47dupAGG | p.Gly16dup | disruptive_inframe_insertion | 1/3 | 1 | NM_001110792.2 | ENSP00000395535.2 | ||
MECP2 | ENST00000303391.11 | c.-116_-114dupAGG | 5_prime_UTR_variant | 1/4 | 1 | NM_004992.4 | ENSP00000301948.6 |
Frequencies
GnomAD3 genomes AF: 0.00181 AC: 189AN: 104180Hom.: 0 Cov.: 20 AF XY: 0.00132 AC XY: 38AN XY: 28794
GnomAD3 genomes
AF:
AC:
189
AN:
104180
Hom.:
Cov.:
20
AF XY:
AC XY:
38
AN XY:
28794
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000863 AC: 62AN: 71845Hom.: 0 AF XY: 0.000640 AC XY: 12AN XY: 18751
GnomAD3 exomes
AF:
AC:
62
AN:
71845
Hom.:
AF XY:
AC XY:
12
AN XY:
18751
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00182 AC: 1683AN: 924111Hom.: 3 Cov.: 26 AF XY: 0.00134 AC XY: 382AN XY: 284099
GnomAD4 exome
AF:
AC:
1683
AN:
924111
Hom.:
Cov.:
26
AF XY:
AC XY:
382
AN XY:
284099
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00181 AC: 189AN: 104220Hom.: 0 Cov.: 20 AF XY: 0.00132 AC XY: 38AN XY: 28838
GnomAD4 genome
AF:
AC:
189
AN:
104220
Hom.:
Cov.:
20
AF XY:
AC XY:
38
AN XY:
28838
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:9
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | curation | RettBASE | May 18, 2012 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 19, 2014 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Sep 24, 2020 | - - |
Severe neonatal-onset encephalopathy with microcephaly Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 18, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Rett syndrome Benign:2
Benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Dec 08, 2022 | The allele frequency of the c.-116_-114dup variant in MECP2 (NM_004992.3) is 0.28% in African/African American sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The c.-116_-114dup variant is observed in at least 2 unaffected individuals (RettBASE) (BS2). In summary, the c.-116_-114dup variant in MECP2 is classified as Benign based on the ACMG/AMP criteria (BA1, BS2). - |
Benign, criteria provided, single submitter | curation | Centre for Population Genomics, CPG | Aug 14, 2023 | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria.Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 2.0 , this variant is classified as Benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 2.0 (BA1). The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2) - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
MECP2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 19, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at